1. Home
  2. ALIT vs ABEO Comparison

ALIT vs ABEO Comparison

Compare ALIT & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alight Inc.

ALIT

Alight Inc.

N/A

Current Price

$8.95

Market Cap

394.4M

ML Signal

N/A

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

N/A

Current Price

$5.05

Market Cap

399.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALIT
ABEO
Founded
2017
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
394.4M
399.5M
IPO Year
2020
2005

Fundamental Metrics

Financial Performance
Metric
ALIT
ABEO
Price
$8.95
$5.05
Analyst Decision
Hold
Strong Buy
Analyst Count
5
7
Target Price
$17.00
★ $18.88
AVG Volume (30 Days)
399.1K
★ 1.3M
Earning Date
11-04-2026
11-11-2026
Dividend Yield
★ 8.97%
N/A
EPS Growth
N/A
★ 165.16
EPS
N/A
★ N/A
Revenue
★ $2,262,000,000.00
$2,998,000.00
Revenue This Year
N/A
$804.33
Revenue Next Year
N/A
$119.68
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 258.18
52 Week Low
$0.48
$4.00
52 Week High
$23.68
$7.65

Technical Indicators

Market Signals
Indicator
ALIT
ABEO
Relative Strength Index (RSI) 28.18 35.55
Support Level $0.56 $4.94
Resistance Level $15.32 $5.46
Average True Range (ATR) 0.75 0.21
MACD -0.31 -0.01
Stochastic Oscillator 1.15 11.39

Price Performance

Historical Comparison
ALIT
ABEO

About ALIT Alight Inc.

Alight Inc is a technology-enabled services company delivering human capital management solutions to many complex organizations. This includes the implementation and administration of employee benefits (e.g., health, wealth, and leave benefits) solutions, which currently operate under one reportable segment, Employer Solutions. The Employer Solutions segment is driven by the Alight Worklife platform, and includes integrated benefits administration, healthcare navigation, financial well-being, leave of absence management, and retiree healthcare. Geographically, the company generates the majority of its revenue from the United States.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Share on Social Networks: